
News|Articles|March 1, 2025
Dermatology Conferences and Meetings Calendar: March 2025
Author(s)Emma Andrus, Editor
Listen
0:00 / 0:00
Key Takeaways
- A list of dermatological meetings for March 2025 has been compiled from reader responses, highlighting anticipated conferences.
- Readers are encouraged to share their conference interests and plans, fostering community engagement and knowledge sharing.
Dermatology Times has compiled a list of dermatological meetings taking place during the month of March.
Advertisement
Dermatology Times has asked our readers to share with us what conferences and meetings they are looking forward to or planning to attend in 2025.
Using these responses, we have compiled a list of dermatological meetings taking place in March.
Interested in sharing what conferences you are interested in or planning to attend this year? Email our team at
March
Orlando, Florida
March 27-30, 2025: Diversity in Dermatology
Louisville, Kentucky
March 27-30, 2025: Multi-Specialty Aesthetic Conference
Hilton Head Island, South Carolina
Use code DT10 for 10% off registration.
Advertisement
Related to this article

The 3rd annual meeting in Atlanta gives dermatology NPs and PAs 4 case-based breakout sessions and a general education session in a focused, small-group setting.

SPD 2026 highlighted advances in pediatric dermatology spanning textured hair care, vitiligo, vascular anomalies, mental health, genetics, and collaborative care.

Two-year oral IL-23 data, GLP-1 biomarker findings, and a nonsurgical option for superficial basal cell carcinoma headline the sessions covered in Las Vegas.

A retrospective claims analysis of 2897 matched pairs found hazard ratios of 0.48 to 0.67 for new atopic disease with dupilumab vs systemic corticosteroids in children.

Prospective data suggest DecisionDx-Melanoma may help refine SLNB decisions and identify recurrence risk beyond conventional staging.

Falk G. Bechara, MD, discusses long-term tunnel control, structural damage, and the evolving role of biologics and surgery in HS care.

In a survey of 301 employed adults, overall work impairment attributable to CHE was 31.8%, and quality of life worsened in step with self-reported disease severity.
Advertisement
Advertisement


